RISPERDAL CONSTA (risperidone) Janssen pharms Patent: 6,667,061 Expiration: Nov 25, 2020 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post D…
Drug Patent Expirations for the Week of November 22, 2020 Read Post »
Annual Drug Patent Expirations for OMEPRAZOLE Omeprazole is a drug marketed by Actavis Labs Fl Inc, Apotex, Aurobindo Pharma Ltd, Breckenridge, Dr Reddys Labs Ltd, Glenmark Generics, Hetero Labs Ltd…
The post New patent for Dexcel Pharma drug OMEPRAZOL…
Annual Drug Patent Expirations for FETZIMA Fetzima is a drug marketed by Allergan and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for Allergan drug FETZIMA appeared first on DrugPat…
Annual Drug Patent Expirations for RISPERDAL+CONSTA Risperdal Consta is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Janssen Pharms drug RISPERDAL CONS…
New patent expiration for Janssen Pharms drug RISPERDAL CONSTA Read Post »
Annual Drug Patent Expirations for RISPERDAL+CONSTA Risperdal Consta is a drug marketed by Janssen Pharms and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Janssen Pharms drug RISPERDAL CONS…
New patent expiration for Janssen Pharms drug RISPERDAL CONSTA Read Post »
This chart shows the pharmaceutical companies with the most tablet dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most tablet dosed drugs…
The post Which pharmaceutical companies have the most tablet…
Which pharmaceutical companies have the most tablet dosed drugs? Read Post »
Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in one NDA. There are seven patents protecting this drug. This drug…
The post New patent for Global Blood drug OXBRYTA appeared first on DrugP…
Annual Drug Patent Expirations for RUBRACA Rubraca is a drug marketed by Clovis Oncology Inc and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent for Clovis Oncology drug RUBRACA appeared first on DrugPat…
Annual Drug Patent Expirations for ODOMZO Odomzo is a drug marketed by Sun Pharma Global and is included in one NDA. It is available from one supplier. There are two…
The post New patent for Sun Pharma drug ODOMZO appeared first on DrugPatentWatch – Ma…
Annual Drug Patent Expirations for ORBACTIV Orbactiv is a drug marketed by Melinta Therap and is included in one NDA. It is available from two suppliers. There are four patents…
The post New patent expiration for Melinta Therap drug ORBACTIV appeared f…
New patent expiration for Melinta Therap drug ORBACTIV Read Post »
Get new actionable insights and updates from BiotechBlog
